CC - 10004
CC-10004 .
作者信息
Khobzaoui Moussa, Gutke Hans-Jürgen, Burnet Michael
机构信息
Synovo GmbH, Paul Ehrlich Strasse 15, D-72076 Tubingen, Germany.
出版信息
Curr Opin Investig Drugs. 2005 May;6(5):518-25.
PMID:15912967
Abstract
CC-10004, a phosphodiesterase 4 inhibitor and selective cytokine inhibitor, is under development by Celgene for the potential treatment of asthma, chronic obstructive pulmonary disease, inflammation and psoriasis. By October 2004, phase II trials in psoriasis had commenced.
摘要
CC-10004是一种磷酸二酯酶4抑制剂和选择性细胞因子抑制剂，正由新基公司进行研发，用于潜在治疗哮喘、慢性阻塞性肺疾病、炎症和银屑病。截至2004年10月，针对银屑病的二期试验已经开始。
Zotero 插件